No photo of Marc R Pritzker
Contact Expert

View Scopus Profile

Marc R Pritzker

1980 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 17 Similar Profiles
Pulmonary Hypertension Medicine & Life Sciences
Heart Transplantation Medicine & Life Sciences
Heart-Assist Devices Medicine & Life Sciences
Heart Failure Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Transplants Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2022

A Phase 3 Open-label, Multicenter Study to Evaluate the

Pritzker, M. R.

LIQUIDIA TECHNOLOGIES, INC

2/8/18 → 3/28/22

Project: Research project

Pulmonary Hypertension
Multicenter Studies
Safety
treprostinil

A Multicenter, Randomized, Double-blind, Placebo control

Pritzker, M. R.

IRONWOOD PHARMACEUTICALS, INC

1/1/18 → 1/30/21

Project: Research project

Heart Failure
Placebos
Safety

Pitch Heart Failure Study: Phosphodiesterase Type 5 Inhi

Pritzker, M. R.

New England Research Institutes

3/31/14 → 12/31/14

Project: Research project

Type 5 Cyclic Nucleotide Phosphodiesterases
Heart Failure
Tadalafil

Clinical Study to Determine Safety, Tolerability

Pritzker, M. R.

IKARIA THERAPEUTICS, LLC

8/1/12 → 7/31/19

Project: Research project

Pulmonary Hypertension
Nitric Oxide
Placebos
Safety
Therapeutics

Research Output 1980 2019

Clinical determinants and prognostic implications of right ventricular dysfunction in pulmonary hypertension caused by chronic lung disease

Prins, K. W., Rose, L., Archer, S. L., Pritzker, M. R., Weir, E. K., Olson, M. D. & Thenappan, T., Jan 1 2019, In : Journal of the American Heart Association. 8, 2, e011464.

Research output: Contribution to journal › Article

Right Ventricular Dysfunction
Pulmonary Hypertension
Lung Diseases
Heart Ventricles
Chronic Disease
2 Citations (Scopus)

Repurposing medications for treatment of pulmonary arterial hypertension: What’s old is new again

Prins, K. W., Thenappan, T., Weir, E. K., Kalra, R., Pritzker, M. R. & Archer, S. L., Jan 1 2019, In : Journal of the American Heart Association. 8, 1, e011343.

Research output: Contribution to journal › Review article

Right Ventricular Function
Pulmonary Hypertension
Pulmonary Artery
1 Citation (Scopus)

Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide

Rose, L., Prins, K. W., Archer, S. L., Pritzker, M. R., Weir, E. K., Misialek, J. R. & Thenappan, T., Feb 1 2019, In : Journal of Heart and Lung Transplantation. 38, 2, p. 145-155 11 p.

Research output: Contribution to journal › Article

Lung Volume Measurements
Carbon Monoxide
Pulmonary Hypertension
Lung Diseases
Chronic Disease

Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients

Holthaus, N., Prins, K. W., Rose, L., Prisco, S., Pritzker, M. R. & Thenappan, T., Jul 1 2019, In : Pulmonary Circulation. 9, 3

Research output: Contribution to journal › Article

Open Access
Epoprostenol
Pulmonary Hypertension
Epoprostenol Receptors
selexipag
Vascular Diseases
4 Citations (Scopus)

Disproportionate right ventricular dysfunction and poor survival in group 3 pulmonary hypertension

Prins, K. W., Rose, L., Archer, S. L., Pritzker, M. R., Weir, E. K., Kazmirczak, F., Misialek, J. R. & Thenappan, T., Jun 1 2018, In : American journal of respiratory and critical care medicine. 197, 11, p. 1496-1499 4 p.

Research output: Contribution to journal › Letter

Right Ventricular Dysfunction
Pulmonary Hypertension